Product image of Nilson (Ceftriaxone) supplied by GNH India

Nilson

Active Ingredient:
Ceftriaxone
Origin:
EU

Nilson (Ceftriaxone)

Ceftriaxone, the active ingredient in Nilson, is a third‑generation cephalosporin presented as an injection for intramuscular use. It treats serious bacterial infections such as pneumonia, meningitis, gonorrhea, urinary tract infections, and skin and soft‑tissue infections in adults and children.
GNH India supplies Nilson as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Dymalife Pharmaceutical S.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ceftriaxone is a broad‑spectrum cephalosporin used to treat infections caused by susceptible bacteria.

  • Community‑acquired pneumonia: provides effective bacterial clearance in lung tissue.
  • Meningitis: achieves high cerebrospinal fluid concentrations to eradicate meningococcal pathogens.
  • Gonorrhea: eliminates Neisseria gonorrhoeae in genital infections.
  • Urinary tract infections: resolves complicated UTIs caused by Gram‑negative organisms.
  • Skin and soft tissue infections: treats cellulitis and wound infections caused by susceptible strains.

How It Works

  • Ceftriaxone binds to penicillin‑binding proteins on the bacterial cell wall, inhibiting the final transpeptidation step of peptidoglycan synthesis. This disruption weakens the wall, leading to osmotic instability, cell lysis, and bacterial death, particularly against Gram‑negative and some Gram‑positive organisms.

Side Effects

Ceftriaxone may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

  • Injection site pain or erythema: localized discomfort at the intramuscular site.
  • Diarrhea: mild to moderate loose stools.
  • Nausea or vomiting: gastrointestinal upset.
  • Elevated liver enzymes: transient increase in hepatic transaminases.
  • Rash: mild skin erythema or pruritus.

Serious or Rare Side Effects

  • Anaphylaxis: severe allergic reaction with airway compromise.
  • Clostridioides difficile colitis: severe diarrhea due to gut flora disruption.
  • Hemolytic anemia: immune‑mediated red cell destruction.
  • Gallbladder sludge or pseudolithiasis: biliary precipitation with prolonged use.

Precautions & Warnings

Ceftriaxone requires careful assessment of patient‑specific factors before use.

  • Renal impairment: monitor renal function and adjust dosing if needed.
  • Hepatic dysfunction: use with caution in patients with liver disease.
  • β‑lactam allergy: avoid in individuals with known cephalosporin or penicillin hypersensitivity.
  • Neonates and infants: watch for bilirubin displacement and kernicterus risk.
  • Pregnancy: risk unknown; prescribe only when benefits outweigh potential hazards.
  • Store at ambient temperature: keep in original container, protect from moisture and light.

Avoid Interactions

Ceftriaxone can interact with several drugs, altering efficacy or safety.

Major Interactions (Avoid)

  • Calcium‑containing IV solutions: precipitate ceftriaxone, causing emboli.
  • Aminoglycosides: increased risk of nephrotoxicity when co‑administered.
  • Anticoagulants (e.g., warfarin): may enhance anticoagulant effect, requiring INR monitoring.
  • Live vaccines: reduced vaccine efficacy; avoid simultaneous administration.

Moderate Interactions (Monitor Closely)

  • Diuretics: may potentiate electrolyte disturbances.
  • Oral contraceptives: possible reduction in contraceptive effectiveness; advise backup method.
  • Probenecid: decreases renal clearance, increasing ceftriaxone levels.

Frequently Asked Questions

Nilson contains ceftriaxone, a broad‑spectrum third‑generation cephalosporin indicated for serious bacterial infections such as community‑acquired pneumonia, meningitis, gonorrhea, urinary tract infections, and skin or soft‑tissue infections caused by susceptible organisms.

Ceftriaxone inhibits bacterial cell‑wall synthesis by binding to penicillin‑binding proteins, blocking the cross‑linking of peptidoglycan strands. This weakens the wall, causing osmotic lysis and death of the bacteria.

The specific dose and dosing interval of Nilson are determined by the prescribing clinician based on the infection type, severity, patient age, weight, renal and hepatic function, and local treatment guidelines.

Safety data for ceftriaxone in pregnancy are limited, and the drug is classified as pregnancy category unknown. It should be used only if the potential benefit justifies any potential risk to the fetus. Caution is also advised during breastfeeding, as small amounts may be excreted in milk.

To request Nilson, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and necessary import documentation.

Nilson (ceftriaxone) offers a long half‑life that allows once‑daily dosing, which can be advantageous over agents like cefotaxime that often require multiple daily doses. Its broad spectrum covers many Gram‑negative and some Gram‑positive pathogens, making it a common choice for severe infections, though susceptibility patterns should guide selection.

Nilson should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the vials from moisture and direct light to maintain stability until the point of use.

Nilson is supplied as a sterile powder for injection and is reconstituted with a compatible diluent. It is administered by intramuscular injection, typically into a large muscle such as the gluteus, following aseptic technique and the prescribing clinician’s instructions.

Serious adverse events include anaphylactic reactions, Clostridioides difficile‑associated colitis, hemolytic anemia, and biliary sludge formation with prolonged therapy. Immediate medical attention is required if signs of severe allergy, persistent diarrhea, or jaundice develop.

Patients with a known hypersensitivity to ceftriaxone, other cephalosporins, or any β‑lactam antibiotics should avoid Nilson. Caution is also advised in neonates, infants, and individuals with severe renal or hepatic impairment, where alternative therapy may be preferred.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ceftriaxone

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT